Murine CD4+ T cell responses are inhibited by Cytotoxic T cell-mediated killing of dendritic cells and are restored by antigen transfer

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Ma, Joel Zhi Iong ^a,b,d   Lim, So Nai ^a,b   Qin, Jim Shixiang ^a,e   Yang, Jianping ^a   Enomoto, Noriyuki ^a,f   Ruedl, Christiane ^c   Ronchese, Franca ^a,b  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e CENTENARY INSTITUTE   (Australia)

^f HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON;

ADOPTIVE TRANSFER; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL KILLING; CELL POPULATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENZYME INHIBITION; LYMPH NODE; MEMORY CELL; MOUSE; NONHUMAN; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; CELL DEATH; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; TRANSGENIC MOUSE;

MURINAE;

ADOPTIVE TRANSFER; ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CELL DEATH; CELL PROLIFERATION; DENDRITIC CELLS; FLOW CYTOMETRY; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84861397061     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037481     Document Type: Article

References (52)

1. Heath WR, Carbone FR, (2001) Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19: 47-64.
2. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, et al. (2002) In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
3. Williams MA, Bevan MJ, (2007) Effector and memory CTL differentiation. Annu Rev Immunol 25: 171-192.
4. Boissonnas A, Scholer-Dahirel A, Simon-Blancal V, Pace L, Valet F, et al. (2010) Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes. Immunity 32: 266-278.
5. Hermans IF, Ritchie DS, Yang J, Roberts JM, Ronchese F, (2000) CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J Immunol 164: 3095-3101.
6. Laffont S, Seillet C, Ortaldo J, Coudert JD, Guery JC, (2008) Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood 112: 661-671.
7. Ritchie DS, Hermans IF, Lumsden JM, Scanga CB, Roberts JM, et al. (2000) Dendritic cell elimination as an assay of cytotoxic T lymphocyte activity in vivo. J Immunol Methods 246: 109-117.
8. Andrew KA, Simkins HM, Witzel S, Perret R, Hudson J, et al. (2008) Dendritic cells treated with lipopolysaccharide up-regulate serine protease inhibitor 6 and remain sensitive to killing by cytotoxic T lymphocytes in vivo. J Immunol 181: 8356-8362.
9. Guarda G, Hons M, Soriano SF, Huang AY, Polley R, et al. (2007) L-selectin-negative CCR7- effector and memory CD8+ T cells enter reactive lymph nodes and kill dendritic cells. Nat Immunol 8: 743-752.
10. Yang J, Huck SP, McHugh RS, Hermans IF, Ronchese F, (2006) Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo. Proc Natl Acad Sci U S A 103: 147-152.
11. Laffont S, Coudert JD, Garidou L, Delpy L, Wiedemann A, et al. (2006) CD8+ T-cell-mediated killing of donor dendritic cells prevents alloreactive T helper type-2 responses in vivo. Blood 108: 2257-2264.
12. Andrews DM, Estcourt MJ, Andoniou CE, Wikstrom ME, Khong A, et al. (2010) Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J Exp Med 207: 1333-1343.
13. Chen M, Felix K, Wang J, (2012) Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation. Blood 119: 127-136.
14. Chen M, Wang YH, Wang Y, Huang L, Sandoval H, et al. (2006) Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311: 1160-1164.
15. Ronchese F, Hermans IF, (2001) Killing of dendritic cells: a life cut short or a purposeful death? J Exp Med 194: F23-26.
16. Enomoto N, Hyde E, Ma JZ, Yang J, Forbes-Blom E, et al. (2012) Allergen-specific CTL require perforin expression to suppress allergic airway inflammation. J Immunol 188: 1734-1741.
17. Ehst BD, Ingulli E, Jenkins MK, (2003) Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am J Transplant 3: 1355-1362.
18. Medema JP, Schuurhuis DH, Rea D, van Tongeren J, de Jong J, et al. (2001) Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J Exp Med 194: 657-667.
19. Mueller SN, Jones CM, Stock AT, Suter M, Heath WR, et al. (2006) CD4+ T cells can protect APC from CTL-mediated elimination. J Immunol 176: 7379-7384.
20. Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN, (1997) Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6: 715-726.
21. Kuipers H, Soullie T, Hammad H, Willart M, Kool M, et al. (2009) Sensitization by intratracheally injected dendritic cells is independent of antigen presentation by host antigen-presenting cells. J Leukoc Biol 85: 64-70.
22. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, et al. (2003) Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19: 47-57.
23. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK, (2001) Visualizing the generation of memory CD4 T cells in the whole body. Nature 410: 101-105.
24. Dickgreber N, Stoitzner P, Bai Y, Price KM, Farrand KJ, et al. (2009) Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapy. J Immunol 182: 1260-1269.
25. Kleindienst P, Brocker T, (2003) Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. J Immunol 170: 2817-2823.
26. Luketic L, Delanghe J, Sobol PT, Yang P, Frotten E, et al. (2007) Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL. J Immunol 179: 5024-5032.
27. Petersen TR, Sika-Paotonu D, Knight DA, Simkins HM, Hermans IF, (2011) Exploiting the Role of Endogenous Lymphoid-Resident Dendritic Cells in the Priming of NKT Cells and CD8+ T Cells to Dendritic Cell-Based Vaccines. PLoS One 6: e17657.
28. Yewdall AW, Drutman SB, Jinwala F, Bahjat KS, Bhardwaj N, (2010) CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells. PLoS One 5: e11144.
29. Wakim LM, Bevan MJ, (2011) Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection. Nature 471: 629-632.
30. Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, et al. (2006) Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25: 153-162.
31. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, et al. (2005) Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654.
32. Bajenoff M, Granjeaud S, Guerder S, (2003) The strategy of T cell antigen-presenting cell encounter in antigen-draining lymph nodes revealed by imaging of initial T cell activation. J Exp Med 198: 715-724.
33. Blair DA, Turner DL, Bose TO, Pham QM, Bouchard KR, et al. (2011) Duration of antigen availability influences the expansion and memory differentiation of T cells. J Immunol 187: 2310-2321.
34. Jusforgues-Saklani H, Uhl M, Blachere N, Lemaitre F, Lantz O, et al. (2008) Antigen persistence is required for dendritic cell licensing and CD8+ T cell cross-priming. J Immunol 181: 3067-3076.
35. Obst R, van Santen HM, Mathis D, Benoist C, (2005) Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response. J Exp Med 201: 1555-1565.
36. Hufford MM, Kim TS, Sun J, Braciale TJ, (2011) Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. J Exp Med 208: 167-180.
37. Brehm MA, Daniels KA, Welsh RM, (2005) Rapid production of TNF-alpha following TCR engagement of naive CD8 T cells. J Immunol 175: 5043-5049.
38. Min L, Mohammad Isa SA, Shuai W, Piang CB, Nih FW, et al. (2010) Cutting edge: granulocyte-macrophage colony-stimulating factor is the major CD8+ T cell-derived licensing factor for dendritic cell activation. J Immunol 184: 4625-4629.
39. Sporri R, Reis e Sousa C, (2005) Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat Immunol 6: 163-170.
40. Badovinac VP, Tvinnereim AR, Harty JT, (2000) Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. Science 290: 1354-1358.
41. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, et al. (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286: 1957-1959.
42. Feldmann J, Le Deist F, Ouachee-Chardin M, Certain S, Alexander S, et al. (2002) Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. Br J Haematol 117: 965-972.
43. Matloubian M, Suresh M, Glass A, Galvan M, Chow K, et al. (1999) A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol 73: 2527-2536.
44. Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, et al. (1998) Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 188: 2163-2173.
45. Kontgen F, Suss G, Stewart C, Steinmetz M, Bluethmann H, (1993) Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int Immunol 5: 957-964.
46. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
47. Barnden MJ, Allison J, Heath WR, Carbone FR, (1998) Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76: 34-40.
48. Garrigan K, Moroni-Rawson P, McMurray C, Hermans I, Abernethy N, et al. (1996) Functional comparison of spleen dendritic cells and dendritic cells cultured in vitro from bone marrow precursors. Blood 88: 3508-3512.
49. Ruedl C, Khameneh HJ, Karjalainen K, (2008) Manipulation of immune system via immortal bone marrow stem cells. Int Immunol 20: 1211-1218.
50. Robinson MJ, Ronchese F, Miller JH, La Flamme AC, (2010) Paclitaxel inhibits killing by murine cytotoxic T lymphocytes in vivo but not in vitro. Immunol Cell Biol 88: 291-296.
51. Bedoui S, Whitney PG, Waithman J, Eidsmo L, Wakim L, et al. (2009) Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol 10: 488-495.
52. Lee HK, Zamora M, Linehan MM, Iijima N, Gonzalez D, et al. (2009) Differential roles of migratory and resident DCs in T cell priming after mucosal or skin HSV-1 infection. J Exp Med 206: 359-370.